Aureka’s $100M Series B: Lab-in-the-Loop Biological Foundation Models
Granite Asia backed Aureka Biotechnologies’ $100M Series B (~$200M cumulative) to scale AuraIDE — closed-loop AI + wet lab for antibody discovery.
Granite Asia backed Aureka Biotechnologies’ $100M Series B (~$200M cumulative) to scale AuraIDE — closed-loop AI + wet lab for antibody discovery.
Gap-fill deep dives for Aug 9–10: Source Foundry’s $400M Sequoia-adjacent chip-tool bet, Firmus’s $2B AI factories, Expedition’s $115M COPD Series B, Prime Intellect’s $130M agent stack, and Noen’s ¥500M home robots.
OLIX announced $312M in Series B at a $3.3B valuation. Here is what was disclosed, what the financing label means, and what investors should verify next.
NavVis announced $85M in Series D. Here is what was disclosed, what the financing label means, and what investors should verify next.
Inevitable AI Group announced $6M in funding round. Here is what was disclosed, what the financing label means, and what investors should verify next.
Index Ventures announced $2B in new and expanded funds. Here is what was disclosed, what the financing label means, and what investors should verify next.